Treatment of bleeding problems associated with progestin-only contraceptives: survey results.
Simple, well-documented, effective and inexpensive management approaches are needed for the short-term control of bleeding in progestin-only contraceptive (POC) users. Long-term continuation may improve if acceptable approaches are found to ameliorate these short-term bleeding problems. Family planning providers and researchers were surveyed on the treatment regimens they used for POC-associated bleeding disturbances. Results from this limited survey indicate that no clear indication exists regarding the duration and, severity of bleeding and spotting requiring pharmacologic intervention. Counseling was seen as a critical factor when considering treatment for these problems. This report presents the results of this survey on the different treatment regimens being used by providers throughout the world to treat POC-associated bleeding disturbances.
Nutley
T
T
Family Health International, Research Triangle Park, NC 27709, USA.
Dunson
T R
TR
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D003271:Contraceptive Agents, Female / Q000009:adverse effects*; D003277:Contraceptives, Oral, Combined; D004343:Drug Implants; D004967:Estrogens / Q000627:therapeutic use; D005260:Female; D006801:Humans; D016912:Levonorgestrel / Q000008:administration & dosage / Q000009:adverse effects; D017258:Medroxyprogesterone Acetate / Q000009:adverse effects; D011372:Progestins / Q000009:adverse effects*; D011795:Surveys and Questionnaires; D014592:Uterine Hemorrhage / Q000139:chemically induced* / Q000188:drug therapy
D000894:Anti-Inflammatory Agents, Non-Steroidal; D003271:Contraceptive Agents, Female; D003277:Contraceptives, Oral, Combined; D004343:Drug Implants; D004967:Estrogens; D011372:Progestins; D016912:Levonorgestrel; D017258:Medroxyprogesterone Acetate